TY  - CONF
AU  - Alten, R.
AU  - Lorenz, H-M.
AU  - Mariette, X.
AU  - Nuesslein, H.
AU  - Galeazzi, M.
AU  - Navarro, F.
AU  - Chartier, M.
AU  - Heitzmann, J.
AU  - Rauch, C.
AU  - Le Bars, M.
PY  - 2017
DO  - 10.1136/annrheumdis-2017-eular.1379
SN  - 0003-4967
UR  - https://hdl.handle.net/10668/27639
T2  - Annals of the rheumatic diseases
LA  - en
PB  - Bmj publishing group
KW  - Subcutaneous formulation
TI  - LESS THAN 5% OF REAL-LIFE PATIENTS WHO SWITCH FROM IV TO SC ABATACEPT IN REAL-WORLD CLINICAL PRACTICE SUBSEQUENTLY SWITCH BACK TO THE IV FORMULATION
TY  - conference output
VL  - 76
ER  -